What Is (3R)-3-hydroxyacyl-CoA hydro-lyase
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 10, 2026
Key Facts
- Catalyzes the third and penultimate step of fatty acid beta-oxidation in mitochondria and peroxisomes
- Uses NAD+ cofactor, which is reduced to NADH during the oxidation reaction
- Primarily processes medium-chain fatty acids with substrate-specific variants for short-chain substrates
- Part of bifunctional enzyme complexes alongside enoyl-CoA hydratase for sequential beta-oxidation
- Deficiency leads to metabolic disorders resembling Zellweger syndrome with accumulation of very long-chain fatty acids
Overview
(3R)-3-hydroxyacyl-CoA dehydrogenase is a critical enzyme in cellular energy metabolism, catalyzing the third step of the fatty acid beta-oxidation pathway. Located in the mitochondrial matrix and peroxisomes, this enzyme oxidizes 3-hydroxyacyl-CoA to 3-ketoacyl-CoA, converting energy-rich substrates into forms that ultimately generate adenosine triphosphate (ATP). The reaction is dependent on NAD+ as a cofactor, which is reduced to NADH during the oxidation process.
This enzyme plays a central role in breaking down fatty acids of varying chain lengths, with specialized variants handling medium-chain, long-chain, and short-chain substrates. The efficiency of this enzyme directly impacts the body's ability to metabolize fats and generate energy, making it essential for maintaining proper metabolic function and cellular energy production across tissues.
How It Works
The catalytic mechanism of (3R)-3-hydroxyacyl-CoA dehydrogenase involves a series of coordinated biochemical steps:
- Substrate Recognition: The enzyme specifically recognizes and binds the 3-hydroxyacyl-CoA substrate in its active site with high stereospecificity, ensuring correct orientation for the oxidation reaction.
- NAD+ Cofactor Binding: NAD+ (nicotinamide adenine dinucleotide) binds to the enzyme, positioning itself to accept electrons and protons during the oxidation reaction that follows substrate binding.
- Hydroxyl Group Oxidation: The enzyme catalyzes oxidation of the hydroxyl group at the 3-carbon position to a keto group, converting the substrate to a 3-ketoacyl-CoA intermediate that serves as the substrate for the next beta-oxidation cycle step.
- NADH Release: Following the oxidation reaction, NAD+ is reduced to NADH, which carries electrons to the electron transport chain for ATP synthesis and regenerates the enzyme for subsequent catalytic cycles.
- Sequential Degradation: The 3-ketoacyl-CoA product undergoes thiolytic cleavage by thiolase, releasing acetyl-CoA and a shortened acyl-CoA that re-enters the beta-oxidation spiral for continued degradation.
Key Comparisons
| Parameter | Mitochondrial HAD | Peroxisomal HAD | SCHAD Variant |
|---|---|---|---|
| Location | Mitochondrial matrix and inner membrane | Peroxisomal matrix | Mitochondria and cytoplasm |
| Substrate Specificity | Medium-chain and long-chain fatty acids | Very long-chain fatty acids (>20 carbons) | Short-chain and methyl-branched substrates |
| Cofactor Requirement | NAD+ → NADH | NAD+ → NADH | NAD+ → NADH |
| Primary Function | Energy production in normal metabolism | Processing excess long-chain fatty acids | Specialized metabolism of short-chain compounds |
| Clinical Significance | Deficiency causes severe metabolic disorders | Involvement in peroxisomal disorders | SCHAD deficiency: hypoglycemia and cardiomyopathy |
Why It Matters
- Energy Production: Every cycle of beta-oxidation involving (3R)-3-hydroxyacyl-CoA dehydrogenase generates NADH, which contributes significantly to ATP synthesis through oxidative phosphorylation in mitochondria.
- Metabolic Flexibility: The enzyme enables cells to shift between carbohydrate and fat metabolism, allowing organisms to use fatty acids as fuel during fasting periods or low carbohydrate availability.
- Disease Relevance: Genetic deficiency of (3R)-3-hydroxyacyl-CoA dehydrogenase results in conditions resembling Zellweger syndrome, characterized by hypotonia, developmental delay, hepatomegaly, and accumulation of very long-chain fatty acids that damage cellular function.
- Metabolic Regulation: The enzyme's activity is controlled by the cellular NADH/NAD+ ratio, allowing feedback regulation of fatty acid oxidation based on energy status and preventing excessive oxidation when energy levels are adequate.
- Therapeutic Target: Understanding this enzyme's function has implications for treating metabolic disorders and designing interventions for lipid storage diseases and fatty acid oxidation defects.
The (3R)-3-hydroxyacyl-CoA dehydrogenase enzyme exemplifies the precision of cellular metabolism, where each enzymatic step is carefully orchestrated to extract maximum energy from nutrient substrates. Its activity integrates multiple levels of regulation, responding to cellular energy demands and nutrient availability, making it a key controller of how our bodies use fat for fuel. Dysfunction of this enzyme highlights how critical proper fatty acid oxidation is for overall metabolic health and neurological development.
More What Is in Daily Life
Also in Daily Life
More "What Is" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
- 3-Hydroxyacyl-CoA Dehydrogenase — WikipediaCC-BY-SA-4.0
- Enoyl-CoA Hydratase — WikipediaCC-BY-SA-4.0
- Beta Oxidation — WikipediaCC-BY-SA-4.0
- 3-Hydroxyacyl-CoA Dehydrogenase — ScienceDirectProprietary
- 3-Hydroxyacyl-CoA Dehydrogenase Deficiency — MedlinePlusPublic Domain
Missing an answer?
Suggest a question and we'll generate an answer for it.